CD4 and tuberculosis: Interestingly, in vivo studies have demonstrated that TB reactivation is not necessarily consequent to CD4 depletion or abrogated by anti-retroviral therapy (ART) initiation but, in fact, may depend on the modulation of chronic immune activation, along with the altered effector T-cell phenotypes and dysregulated T-cell homeostasis [11,12].